Smart Rx Systems (2023)

Smart Rx Systems (2023)

About this raise

Smart Rx Systems is raising independently through Reg A+ crowdfunding. The company has developed an on-demand medication dispensing kiosk. The kiosk is called Smart PharmAssist and helps people to get their medication when and where they need it the most. It functions on a remote pharmacy dispensing technology and offers people access to multi-lingual pharmacy services 24 hours a day, seven days a week. The users can also get remote consultations with a pharmacist and get their prescriptions filled quickly and safely. Mathow Sandeep and Swatantra Rohatgi founded Smart Rx Systems in 2013. The current crowdfunding campaign has a maximum target of $50,000,000. The campaign proceeds will be used for acquisitions, working capital, and general corporate purposes.

Expand

Investment Overview

Funding data not publicly available

Deal Terms

Platform
Self Managed
Start Date
08/09/2022
Close Date
09/29/2023
Min. Goal
$10,000
Max Goal
$50,000,000
Min. Investment

$10,000

Security Type

Equity - Preferred

Company Stage

Growth Stage

SEC Filing Type

RegA+    Open SEC Filing

Price Per Share

$10.00

Pre-Money Valuation

$35,012,500

Company & Team

Company

Year Founded
2013
Industry
Healthcare & Pharmaceuticals
Tech Sector
Medtech
Distribution Model
B2B
Margin
Medium
Capital Intensity
High
Location
Lutz, Florida
Business Type
Growth
Company Website
Visit Website

Team

Employees
18
Prior Founder Exits?
No
Founder Name
Sandeep Mathow
Title
Consultant
Founder Name
Santu Rohatgi
Title
COO, Chairman & President

Funding data not publicly available

Financials

 Revenue +29% YoY
$1,736,221
 Monthly Burn
$223,520
 Runway
0.3 months

Balance Sheet

Cash and Cash Equivalents

$64,701

Accounts and Notes Receivable

$162,518

Property, Plant and Equipment (PP&E)

$1,214,121

Total Assets

$8,155,832

Accounts Payable & Accrued Liabilities

$2,052,846

Long Term Debt

$1,910,542

Total Liabilities

$3,963,389

Total Stockholders' Equity

$4,192,443

Total Liabilities and Equity

$8,155,832

Statement of Comprehensive Income Information

Total Revenues

$1,736,221

Costs & Expenses Applicable to Rev

$3,389,513

Depreciation and Amortization

$499,716

Net Income

$-2,682,237

Earnings Per Share - Basic

$-3.45

Earnings Per Share - Diluted

$-1.60

Auditor: Soto Accounting, LLC
Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Company Funding & Growth

Funding history

Total Prior Capital Raised
$0
VC Backed?
No
Close Date Platform Valuation Total Raised Security Type Status Reg Type
06/04/2026 Andes Capital - - Equity - Preferred Active RegA+
09/29/2023 Self Managed $35,012,500 - Equity - Preferred Withdrawn RegA+
Create a free account today to gain access to Kingscrowd analytics.

Growth Charts

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Smart Rx Systems on Self Managed 2022
Platform: Self Managed
Security Type: Equity - Preferred
Valuation: $35,012,500
Price per Share: $10.00

Follow company

Follow Smart Rx Systems on Self Managed 2022
Withdrawn

Buy Smart Rx Systems's Deal Report

Warning: according to the close date for this deal, Smart Rx Systems may no longer be accepting investments.

Smart Rx Systems Deal Report

Get Kingscrowd's comprehensive report on Smart Rx Systems including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Smart Rx Systems is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Smart Rx Systems deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge